A generic concept has been proposed for COVID-19 protein subunit vaccines, which is the vaccine technology platform that is used by the COVID-19 Novavax vaccine product.
The proposed concept is as follows:
FSN: Vaccine product containing* only* Severe acute respiratory syndrome coronavirus 2 recombinant protein antigen
Semantic tag: medicinal product
PT: Canadian Preferred term could remain as proposed, COVID-19 protein subunit vaccine